DEVELOPING
Importance
72
Trust
73
Urgency
65
COMMERCIAL · PRIMARY SOURCE
Foundayo and Zepbound now covered for millions of Americans
Eli Lilly said CVS Caremark will start covering its weight-loss drugs Foundayo and Zepbound for millions of Americans starting in June and October. Eligible patients may pay only $25 per month for their medicine.
Analysis
Millions of Americans may soon pay just $25/month for Lilly's weight-loss drugs. Broader coverage through CVS Caremark means more patients can afford Zepbound and Foundayo.
- CVS Caremark will cover Foundayo and Zepbound starting in June and October
- Eligible patients may pay $25 per month for their medicine
Eli Lilly Press Releases23d
Read